fashion -WSS

fashion

author：comprehensive 2025-09-29 21:27:56 - browse：8141

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： WHO recommends dropping component of many flu vaccines

WSS

Medicaid, Medicare dual

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Providers still hesitate to prescribe buprenorphine, study finds

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Did you have Obamacare on your GOP debate bingo card?

HIPAA doesn't protect reproductive records from prosecutors

leisure time

fashion

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Affirmative action in medical school literally saved lives

Listen: Who gets the credit for GLP

Supreme Court strikes down use of affirmative action

7 of the most gruesome medical devices in history

Wildfire smoke exposes gaps in outdoor worker protections

Biogen shutters digital health group, ends Apple study, in cost cutting move

In age of alternative facts, a scholarly course on calling out crap

AbbVie dramatically boosts its spending on lobbying

hotspot

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Intercept Pharmaceuticals sells itself for less than $1 billion

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Senator probes 340B programs at Cleveland Clinic, Bon Secours

hotspot

leisure time

hotspot

explore